• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Newer blood thinner plus aspirin reduced stroke risk by 27% in patients with heart plaque
(American Heart Association) Patients who suffered a 'warning stroke' were less likely to have another stroke or die within 30 days if treated with a combination of aspirin and a newer blood thinner, ticagrelor. Researchers say that for patients with minor stroke treated within 24 hours of symptom onset, clinicians should consider the combination of ticagrelor plus aspirin to prevent a subsequent stroke.
Source: EurekAlert! - Medicine and Health - November 17, 2020 Category: International Medicine & Public Health Source Type: news

Ticagrelor alone, without aspirin, shows benefit in patients with diabetes
(American College of Cardiology) Patients with diabetes who stopped taking aspirin three months after the insertion of a coronary stent and then took the anti-platelet medication ticagrelor alone for a year had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor for a year. The research was presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news

Aspirin's health benefits under scrutiny
(University of Georgia) Taking a baby aspirin every day to prevent a heart attack or stroke should no longer be recommended to patients who haven't already experienced one of these events.
Source: EurekAlert! - Medicine and Health - December 9, 2019 Category: International Medicine & Public Health Source Type: news

Stopping aspirin three months after stenting does not increase risk of death
(American College of Cardiology) Patients who stopped taking aspirin three months after receiving a stent to open the heart's arteries but continued taking a P2Y12 inhibitor -- clopidogrel, prasugrel or ticagrelor -- did not experience higher rates of death from any cause, heart attack or stroke after a year compared with those receiving standard therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. Furthermore, patients who stopped taking aspirin after three months had a significantly lower rate of bleeding.
Source: EurekAlert! - Medicine and Health - March 18, 2019 Category: International Medicine & Public Health Source Type: news

Cilostazol-combo antiplatelet therapy reduced risk for recurrent stroke
(American Heart Association) The long-term combination of cilostazol with aspirin or clopidogrel resulted in fewer recurrent strokes than with aspirin or clopidogrel alone in high-risk patients.
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news

Aspirin may lower stroke risk in women with history of preeclampsia
(Columbia University Irving Medical Center) A new study by Columbia researchers suggests aspirin may lower stroke risk among middle-aged women with a history of preeclampsia.
Source: EurekAlert! - Medicine and Health - January 22, 2019 Category: International Medicine & Public Health Source Type: news

International study suggests combination therapy may prevent stroke in certain people
(NIH/National Institute of Neurological Disorders and Stroke) Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and aspirin following a small stroke or experiencing minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days. The combination therapy was also associated with an increase in major bleeding, although many of those episodes were non-fatal and did not occur in the brain.
Source: EurekAlert! - Medicine and Health - May 17, 2018 Category: International Medicine & Public Health Source Type: news

Stroke prevention drug combo shows promise, study says
(University of Texas at Austin) If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research published in The New England Journal of Medicine.
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Aspirin lowers risk of death for patients with diabetes, heart failure
(American College of Cardiology) For people living with both Type 2 diabetes and heart failure, taking an aspirin each day appears to lower the risk of dying or being hospitalized for heart failure, according to research being presented at the American College of Cardiology's 67th Annual Scientific Session. But the data also reveal aspirin use may increase the risk of nonfatal heart attack or stroke, a somewhat contradictory finding that surprised researchers.
Source: EurekAlert! - Medicine and Health - February 28, 2018 Category: International Medicine & Public Health Source Type: news

NIH-led study explores prevention of heart disease in HIV-infected people
(NIH/National Institute of Allergy and Infectious Diseases) The National Institutes of Health has launched a clinical trial to assess the effects of aspirin and cholesterol-lowering drugs, or statins, on preventing cardiovascular disease in people with long-term HIV infections. This group, which includes people on antiretroviral therapy as well as 'elite controllers' who can limit the virus without antiretroviral therapy, have a higher risk of developing heart disease and stroke compared to the general population.
Source: EurekAlert! - Medicine and Health - October 28, 2014 Category: Global & Universal Source Type: news

Baby aspirin? Many doctors don't recommend, despite guidelines
(University of Rochester Medical Center) A majority of middle-aged men and women eligible to take aspirin to prevent heart attack and stroke do not recall their doctors ever telling them to do so, according to a University of Rochester study of a national sample of more than 3,000 patients.
Source: EurekAlert! - Medicine and Health - August 5, 2014 Category: Global & Universal Source Type: news

A new form of aspirin to overcome 'aspirin resistance'
(American Chemical Society) Scientists are reporting development of a new form of aspirin -- taken daily by about 60 million people in the United States alone to reduce the risk of heart attack and stroke -- that could extend aspirin's benefits to people who may not respond to the drug. Their advance toward coping with "aspirin resistance" appears in the journal ACS Nano.
Source: EurekAlert! - Medicine and Health - September 4, 2013 Category: Global & Universal Source Type: news

Low-dose anticoagulation therapy used with new design mechanical heart valve lowers bleeding risk
(American Association for Thoracic Surgery) Investigators show that lower dose anticoagulation therapy, combined with low-dose aspirin, resulted in a reduction of 55 to 60 percent of the incidence of adverse bleeding events without significant increases in stroke, transient ischemic attack or total neurological events when used in conjunction with the On-X mechanical aortic valve.
Source: EurekAlert! - Medicine and Health - May 6, 2013 Category: Global & Universal Source Type: news

First of its kind study in Canada looks at who is taking aspirin to prevent heart attack or stroke
(University of Alberta Faculty of Medicine & Dentistry) A new study out of the Faculty of Medicine & Dentistry shows a large population of healthy people are taking Aspirin to prevent cardiovascular disease, despite the fact that new literature shows it isn't as beneficial as once thought.
Source: EurekAlert! - Medicine and Health - March 19, 2013 Category: Global & Universal Source Type: news